NASDAQ:CME - CME Group Stock Price, Price Target & More

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a quarterly dividend on Tuesday, May 8th. Stockholders of record on Friday, June 8th will be paid a dividend of $0.70 per share on Monday, June 25th. This represents a $2.80 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend is Thursday, June 7th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings data on Thursday, April, 26th. The financial services provider reported $1.86 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.01. The financial services provider earned $1.10 billion during the quarter, compared to the consensus estimate of $1.12 billion. CME Group had a net margin of 111.45% and a return on equity of 8.48%. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.22 EPS. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for CME Group.

13 brokerages have issued 1 year target prices for CME Group's shares. Their forecasts range from $133.00 to $197.00. On average, they expect CME Group's share price to reach $169.5385 in the next year. This suggests a possible upside of 0.4% from the stock's current price. View Analyst Ratings for CME Group.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price Group (TROW), DEUTSCHE BOERSE/ADR (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).

News articles about CME stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.10 on Accern's scale. They also gave media coverage about the financial services provider an impact score of 45.62 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

CME Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Pendal Group Ltd (0.20%), KAMES CAPITAL plc (0.15%), Miller Howard Investments Inc. NY (0.13%), Bank of Montreal Can (0.12%), Gateway Investment Advisers LLC (0.07%) and Franklin Street Advisors Inc. NC (0.05%). Company insiders that own CME Group stock include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Pendal Group Ltd, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clinton Group Inc., Hartford Investment Management Co., Nippon Life Global Investors Americas Inc., Nisa Investment Advisors LLC and Miller Howard Investments Inc. NY. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was bought by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, NN Investment Partners Holdings N.V., Westpac Banking Corp, Cornerstone Wealth Management LLC, State of Alaska Department of Revenue, Chicago Capital LLC, Nadler Financial Group Inc. and LS Investment Advisors LLC. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $168.88.

CME Group has a market capitalization of $58.05 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]